2019 annual financial data

Tarsus Pharmaceuticals 2019 Operating margin

Tarsus Pharmaceuticals 2019 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -4,298,000 USD and net income was -4,670,000 USD.
Operating cash flow was -3,673,000 USD.

Get free Tarsus Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-4,298,000 USD
Net income
-4,670,000 USD
Operating cash flow
-3,673,000 USD